tDCS as an add-on Treatment in SSRI-resistant OCD

NCT02407288 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hôpital le Vinatier